Cambia Board

Richard A. Jefferson

personimageChief Executive Officer, Cambia

Professor Richard Jefferson, CEO of Cambia, is Chair of the Cambia Board.

Since establishing Cambia in 1991, Richard has continued to oversee the development of new science- and technology-enabled tools for the public good.

Dr. Russell J. Howard

personimageCEO, Oakbio Inc.

Dr. Russell J. Howard is an Australian-born scientist, CEO and entrepreneur. He was a pioneer in the fields of molecular parasitology, especially malaria, and in leading the commercialization of one of the most important methods used widely today. While Dr. Howard was President and Scientific Director at Affymax Research Institute, Willem 'Pim' Stemmer conceived and developed DNA Shuffling Technology. This revolutionary technology for improving the expressed phenotype of genes, pathways, plasmids, viruses and genomes gave birth to the creation and spinout of Maxygen Inc. where Dr Howard was CEO for 12 years. He took the company public and led its growth with 10’s of corporate partnerships, technology application programs that led ultimately to the development and commercialization worldwide of 10’s of Life Science products in diverse fields. In 2008 Dr. Howard left Maxygen to found Oakbio Inc. He is currently a founder and the CEO of Oakbio Inc. in Sunnyvale, California, USA, a company designing microbes for production of cost-competitive chemicals using industrial CO2 emissions as carbon source. Dr. Howard has published over 140 scientific publications in refereed journals and is an inventor on five issued patents.

Beth Noveck

personimageProfessor of Law, New York Law School

Currently Professor of Law at New York Law School, Dr. Beth Noveck served in the White House as United States Deputy Chief Technology Officer (2009-2011) and leader of the White House Open Government Initiative . As a result of this initiative, today every department and agency has an Open Government Plan, and citizens have burgeoning opportunities to participate in their democracy.

Noveck founded the Democracy Design Workshop Do Tank.  Together with students at New York Law School and numerous partners, she designed and built the U.S. government’s first expert network . 

She developed the Cairns Project, graphical software to support group formation and collaboration; Democracy Island, an experimental space within a virtual world for research on citizen participation; and “IOPedia,” a platform for mashing up and visualizing public corporate accountability data and tracking the evolution of organizations.

She also founded the State of Play conference, the first (and still ongoing annual) conference on videogames, virtual worlds and society. With the support of the MacArthur Foundation in 2011-12, she is developing an agenda for interdisciplinary research on institutional innovation.

Michael Rabson

personimagePartner, Wilson Sonsini Goodrich & Rosati

Dr. Michael Rabson is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on counseling biotechnology companies, including those in the biopharmaceutical, diagnostics, clean technology, and agricultural biology industries.

Until recently Dr. Michael Rabson was Senior Vice President, Business Development & Legal Affairs, and General Counsel of Cytokinetics, a biotechnology company dedicated to the discovery, development, and commercialization of innovative therapeutics. Before that, Michael served as General Counsel and Senior Vice President at Maxygen.

Michael has handled the licensing of patents from Cambia Biosystems, and was instrumental in refining the drafts of the BiOS (Biological Open Source) license.

An expert in Intellectual Property, Michael has also been patent examiner at the United States Patent and Trademark Office (USPTO), having a particular focus on patents in biotechnology and genetic engineering.

Michael received a BS in Biological Sciences from Cornell University. He holds a PhD in infectious disease epidemiology from Yale University, and a JD from Yale Law School. He was post-doctoral fellow at the National Cancer Institute, National Institutes of Health.

Antony Taubman

personimageDirector, Intellectual Property Division, World Trade Organization (WTO)

Antony Taubman is currently Director, Intellectual Property Division, World Trade Organization (WTO), with responsibility for intellectual property, competition and government procurement. He was previously the acting director and head of the Global Intellectual Property Issues Division of the World Intellectual Property Organization (WIPO), a position he assumed in May 2002. After a diplomatic career, he left the Australian Department of Foreign Affairs and Trade (DFAT) in 2001 to join the newly-formed Australian Center for Intellectual Property in Agriculture, at the Australian National University in Canberra, teaching and researching on international IP law. He has also held a teaching appointment at the School of Law at the University of Melbourne. From 1998 to 2001, he was the director of the International Intellectual Property Section of DFAT. He has authored a training handbook on intellectual property and biotechnology, a comprehensive study on the implementation of the TRIPS Agreement, and a range of academic and general publications on international intellectual property law and policy. As a registered patent attorney, he has also worked in private practice in the law of patents, trade marks and designs. He has been awarded two academic prizes for postgraduate law from the University of Edinburgh, United Kingdom.

Comments (0)